Samsung Pharmaceutical Co (XKRX:001360) Cash-to-Debt : 7.19 (As of Dec. 2023)

View and export this data going back to 1975. Start your Free Trial

What is Samsung Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Samsung Pharmaceutical Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 7.19.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Samsung Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Samsung Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

XKRX:001360' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.12 Med: 1.69 Max: 30.38
Current: 7.19

During the past 13 years, Samsung Pharmaceutical Co's highest Cash to Debt Ratio was 30.38. The lowest was 0.12. And the median was 1.69.

XKRX:001360's Cash-to-Debt is ranked better than
74.43% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.945 vs XKRX:001360: 7.19

Samsung Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Samsung Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Samsung Pharmaceutical Co Cash-to-Debt Chart

Samsung Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

2.34

1.03

30.38

27.99

7.19

Samsung Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															27.99	31.03	15.73	8.43	7.19

Competitive Comparison of Samsung Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Samsung Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Samsung Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samsung Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Samsung Pharmaceutical Co's Cash-to-Debt falls into.

Samsung Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Samsung Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4281.308	/	(493.668	+	101.818)
	=	7.19

Samsung Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4281.308	/	(493.668	+	101.818)
	=	7.19

Samsung Pharmaceutical Co (XKRX:001360) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Samsung Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Samsung Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung Pharmaceutical Co (XKRX:001360) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samsung Pharmaceutical Co Ltd (XKRX:001360) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

35 Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong, KOR, 445-746

Website

http://www.sspharm.co.kr

Samsung Pharmaceutical Co Ltd is a South Korea based company engages in the manufacturing, supply, and distribution of pharmaceutical products. The company offers over the counter (OTC) drugs, prescription drugs, energy drinks, insecticides, and healthcare food items.

Samsung Pharmaceutical Co (XKRX:001360) Headlines

No Headlines